News | July 17, 2024
Mankind Pharma signs agreement with Takeda to commercialize Vonoprazan in India
Vonoprazan is a potassium-competitive acid blocker (P-CAB) used for the treatment of acid-related disorders
Vonoprazan is a potassium-competitive acid blocker (P-CAB) used for the treatment of acid-related disorders
Findings from the SEIMC-GeSIDA Foundation (FSG) PASO-DOBLE study will include treatment efficacy, safety, and weight gain
Shoff brings over 30 years of international experience in in vitro diagnostics, healthcare distribution and veterinary diagnostics
Acquisition strengthens and diversifies Merck’s pipeline with the addition of Restoret
Selexipag is a prostacyclin receptor agonist indicated for the treatment of pulmonary arterial hypertension
The company is planning to expand its plant capacity in in Vapi
Enhanced collaboration under the Memorandum of Cooperation (MoC) between India and Japan in medical product regulations
The agreement has an initial term until March 31, 2029 and no further details on the financial terms of the deal are being disclosed
The approved ANDA is therapeutically equivalent to the reference listed drug product
Acquisition to expand Lilly's immunology pipeline with oral integrin therapies
Subscribe To Our Newsletter & Stay Updated
